فاس نيوز ميديا جريدة الكترونية جهوية تعنى بشؤون و أخبار جهة فاس مكناس – متجددة على مدار الساعة
SIGA Technologies has announced a significant agreement with the Kingdom of Morocco to supply the Ministry of Health and Social Protection with “Tpoxx,” a treatment designed to combat mpox (formerly known as monkeypox).
This move is part of Morocco’s efforts to strengthen its preventive readiness against potential outbreaks of the disease. With this agreement, Morocco becomes the first African nation to commercially acquire the antiviral medication, a step taken in line with the royal directives of His Majesty King Mohammed VI, which emphasize the importance of enhancing the country’s healthcare and pharmaceutical sovereignty.
The deal aligns with the royal vision to bolster national health security, enabling Morocco to better face future health challenges and meet its needs for essential medications.
While “Tpoxx” had previously been available in Africa through clinical trials and emergency use protocols issued by the World Health Organization (WHO), this agreement marks a significant shift, as the treatment will now be commercially available in the country.
Currently, “Tpoxx” is approved in the United States and Canada for the treatment of smallpox and has also received licenses in Europe and the United Kingdom for treating diseases such as mpox, smallpox, and cowpox, as well as addressing side effects from smallpox vaccines.
Victor Gomez, Vice President of International Markets at SIGA Technologies, commented on the agreement: “At SIGA, we are committed to expanding access to Tpoxx globally.
We are delighted to introduce this treatment in Morocco as a crucial preventive measure against viral diseases like smallpox.
We extend our gratitude to the Moroccan Ministry of Health and Social Protection for their strong support, which made this swift process possible.”
This announcement follows the WHO’s classification of mpox as a public health emergency of international concern in August, particularly with the emergence of new virus variants.
Through this agreement, Morocco strengthens its position as a leading nation in Africa in terms of health preparedness, reinforcing its commitment to achieving sustainable health security.
source: fesnews media
